HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
1-Year Return
22.29%
This Quarter Return
+3.03%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$49.4M
AUM Growth
-$19.9M
(-29%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-35.85%
Top 10 Holdings %
Top 10 Hldgs %
90.12%
Holding
33
New
4
Increased
6
Reduced
2
Closed
8
Top Buys
| 1 |
AstraZeneca
AZN
|
$1.76M |
| 2 |
AMRI
Albany Molecular Research Inc
AMRI
|
$1.63M |
| 3 |
Pfizer
PFE
|
$1.56M |
| 4 |
Artivion
AORT
|
$1.42M |
| 5 |
QLTI
QLT Inc
QLTI
|
$1.4M |
Top Sells
| 1 |
ANI Pharmaceuticals
ANIP
|
$9.9M |
| 2 |
AGN
Allergan plc
AGN
|
$7.24M |
| 3 |
ProShares UltraShort Russell2000
TWM
|
$4.95M |
| 4 |
ProShares UltraShort NASDAQ Biotechnology
BIS
|
$2.41M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.13M |
Sector Composition
| 1 | Healthcare | 85.45% |